The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The impacts on prognosis of the relationship between decline in renal function associated with pemetrexed and the ratio of pemetrexed administration.
 
Yuta Yamanaka
No Relationships to Disclose
 
Kenta Murotani
No Relationships to Disclose
 
Hiroshige Yoshioka
Honoraria - Amgen; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Chugai Pharma; Daiichi Sankyo; Delta-Fly Pharma; Lilly; Merck; MSD K.K; Nippon Kayaku; Novartis; Ono Pharmaceutical; Otsuka; Pfizer; Taiho Pharmaceutical; Takeda
Consulting or Advisory Role - Delta-Fly Pharma
Research Funding - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Daiichi Sankyo (Inst); Delta-Fly Pharma (Inst); Janssen (Inst); MSD (Inst); Novartis (Inst)
 
Kazuki Fujii
No Relationships to Disclose
 
Yutaro Nagata
No Relationships to Disclose
 
Yukiko Okuno
No Relationships to Disclose
 
Keisuke Kamisako
No Relationships to Disclose
 
Yuta Okazaki
No Relationships to Disclose
 
Kentaro Nakanishi
No Relationships to Disclose
 
Kiyori Yoshida
No Relationships to Disclose
 
Tatsuki Ikoma
No Relationships to Disclose
 
Yuki Takeyasu
No Relationships to Disclose
 
Utae Katsushima
No Relationships to Disclose
 
Takayasu Kurata
Honoraria - Amgen; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Chugai Pharma; Daiichi Sankyo/UCB Japan; Lilly; MSD Oncology; Nippon Kayaku; Ono Pharmaceutical; Pfizer; Takeda
Research Funding - Amgen; AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Daiichi Sankyo/Astra Zeneca; Janssen; MSD Oncology (Inst); Takeda (Inst)